POLL: Are you attending Fall Clinical Dermatology Conference 2021 this weekend?

Click here to answer this week's poll.

Yes (in person)
Yes (Virtually)
No
Related Videos
Related Content

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.